Standard InChI: InChI=1S/C18H17Cl3N6O2/c1-18(20,21)16(26-14(28)11-5-7-12(19)8-6-11)27-17(24-10-22)25-13-4-3-9-23-15(13)29-2/h3-9,16H,1-2H3,(H,26,28)(H2,24,25,27)
Standard InChI Key: PCYQNSRPJFTODK-UHFFFAOYSA-N
Associated Targets(Human)
KCNJ11TclinPotassium channel, inwardly rectifying, subfamily J, member 11 (112 Activities)
1.Perez-Medrano A, Brune ME, Buckner SA, Coghlan MJ, Fey TA, Gopalakrishnan M, Gregg RJ, Kort ME, Scott VE, Sullivan JP, Whiteaker KL, Carroll WA.. (2007) Structure-activity studies of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladder., 50 (24):[PMID:17973362][10.1021/jm7010194]
2.Perez-Medrano A, Donnelly-Roberts DL, Honore P, Hsieh GC, Namovic MT, Peddi S, Shuai Q, Wang Y, Faltynek CR, Jarvis MF, Carroll WA.. (2009) Discovery and biological evaluation of novel cyanoguanidine P2X(7) antagonists with analgesic activity in a rat model of neuropathic pain., 52 (10):[PMID:19397270][10.1021/jm8015848]